Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ester Lozano

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Leukemia|February 22, 2018
Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progressionCarlos Fernández de Larrea, Ignacio Isola, Arturo Pereira, et al.
Frontiers in Immunology|December 9, 2021
Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic DiseaseIgnacio Isola, Fara Brasó-Maristany, David F Moreno, et al.
Immunity|April 22, 2014
Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responsesNicole Joller, Ester Lozano, Patrick R Burkett, et al.
Frontiers in Genetics|June 13, 2020
Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected PatientsMaria Bañó, Constanza Morén, Sergio Barroso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2024
Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple MyelomaEster Lozano, Mari-Pau Mena, Glòria Garrabou, et al.
International Journal of Molecular Sciences|August 10, 2024
Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIVSergio Barroso, Mariona Guitart-Mampel, Francesc Josep García-García, et al.
Annals of the Rheumatic Diseases|April 30, 2013
Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritisMarc Corbera-Bellalta, Ana García-Martínez, Ester Lozano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 2018
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple MyelomaEster Lozano, Tania Díaz, Mari-Pau Mena, et al.
Frontiers in Oncology|July 22, 2022
Long-Term Responders After Autologous Stem Cell Transplantation in Multiple MyelomaAina Oliver-Caldes, Juan Carlos Soler-Perromat, Ester Lozano, et al.
Frontiers in Immunology|July 16, 2025
Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond <i>MYD88</i> L265PDavid F Moreno, Ferran Nadeu, Fara Brasó-Maristany, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Leukemia|February 22, 2018
Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progressionCarlos Fernández de Larrea, Ignacio Isola, Arturo Pereira, et al.
Frontiers in Immunology|December 9, 2021
Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic DiseaseIgnacio Isola, Fara Brasó-Maristany, David F Moreno, et al.
Immunity|April 22, 2014
Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responsesNicole Joller, Ester Lozano, Patrick R Burkett, et al.
Frontiers in Genetics|June 13, 2020
Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected PatientsMaria Bañó, Constanza Morén, Sergio Barroso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2024
Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple MyelomaEster Lozano, Mari-Pau Mena, Glòria Garrabou, et al.
International Journal of Molecular Sciences|August 10, 2024
Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIVSergio Barroso, Mariona Guitart-Mampel, Francesc Josep García-García, et al.
Annals of the Rheumatic Diseases|April 30, 2013
Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritisMarc Corbera-Bellalta, Ana García-Martínez, Ester Lozano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 2018
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple MyelomaEster Lozano, Tania Díaz, Mari-Pau Mena, et al.
Frontiers in Oncology|July 22, 2022
Long-Term Responders After Autologous Stem Cell Transplantation in Multiple MyelomaAina Oliver-Caldes, Juan Carlos Soler-Perromat, Ester Lozano, et al.
Frontiers in Immunology|July 16, 2025
Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond <i>MYD88</i> L265PDavid F Moreno, Ferran Nadeu, Fara Brasó-Maristany, et al.
Pageof 4